Game-Changer for Indian Dairy: IIL Unveils First Indigenous DIVA Marker Vaccine Against IBR

In a landmark achievement poised to transform India's livestock industry, Indian Immunologicals Limited (IIL) has announced the launch of 'Raksha IBR', the nation's first GE-deleted DIVA marker vaccine against Infectious Bovine Rhinotracheitis (IBR). This revolutionary vaccine is set to provide a much-needed shield for cattle, protecting them from a highly contagious disease that has long plagued dairy farmers and caused significant economic setbacks.

IBR, caused by the Bovine Herpesvirus 1, is a formidable adversary for cattle, manifesting in severe respiratory and reproductive problems, including abortions, stillbirths, and infertility.

Its widespread presence has historically led to substantial financial losses for the dairy sector, impacting milk production and the overall health of animal herds. The introduction of 'Raksha IBR' represents a critical step forward in mitigating these challenges.

What sets 'Raksha IBR' apart is its groundbreaking DIVA (Differentiating Infected from Vaccinated Animals) marker technology.

This innovative feature allows veterinarians and farmers to distinguish between animals that have been vaccinated and those that have been naturally infected with the IBR virus. This capability is absolutely crucial for effective disease management and control programs, enabling targeted interventions and preventing the misidentification of infected animals.

For countries aiming for disease-free status, a DIVA vaccine is indispensable for robust surveillance and eradication strategies.

The development of 'Raksha IBR' is a testament to India's growing prowess in indigenous biotechnological innovation. It was developed in collaboration with the Indian Council of Agricultural Research - Indian Veterinary Research Institute (ICAR-IVRI), underscoring the power of joint scientific endeavors.

This 'Make in India' initiative not only bolsters the nation's self-reliance in animal health but also offers a cost-effective and readily available solution tailored to local needs.

For the average dairy farmer, the implications of 'Raksha IBR' are profound. The vaccine promises enhanced protection for their valuable livestock, translating into healthier cattle, increased milk yields, and reduced economic losses from disease outbreaks.

It empowers farmers with a vital tool to safeguard their livelihood and contribute to a more robust and sustainable dairy industry. This development marks a significant stride towards ensuring animal welfare and elevating the standards of livestock health across India, solidifying IIL's commitment to advancing veterinary science.